Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04573660

Abbott Vascular Medical Device Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,784 (estimated)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.

Conditions

Interventions

TypeNameDescription
DEVICECoronary and peripheral stentsThe participants in the Coronary and peripheral stents arm will receive Coronary and peripheral stents
DEVICEPacing cathetersThe participants in the Pacing catheters arm will receive Pacing catheters
DEVICEVascular plugsThe participants in the Vascular plugs arm will receive Vascular plugs
DEVICEMeasurement and imaging (FFR and OCT)The participants in the Measurement and imaging (FFR and OCT) arm will receive Measurement and imaging (FFR and OCT)
DEVICEPeripheral dilatation cathetersThe participants in the Peripheral dilatation catheters will receive Peripheral dilatation catheters
DEVICECoronary dilatation cathetersThe participants in the Coronary dilatation catheters will receive Coronary dilatation catheters
DEVICECoronary and peripheral guidewiresThe participants in the Coronary and peripheral guidewires will receive Coronary and peripheral guidewires
DEVICEVessel closure/compression devicesThe participants in the Vessel closure/compression devices will receive Vessel closure/compression devices
DEVICEVascular access introducersThe participants in the Vascular access introducers arm will receive Vascular access introducers

Timeline

Start date
2020-10-25
Primary completion
2030-11-01
Completion
2031-11-01
First posted
2020-10-05
Last updated
2025-07-03

Locations

37 sites across 14 countries: United States, Australia, Austria, Belgium, China, France, Germany, Hungary, Italy, Netherlands, Spain, Switzerland, Taiwan, United Arab Emirates

Source: ClinicalTrials.gov record NCT04573660. Inclusion in this directory is not an endorsement.